Anzeige
Mehr »
Montag, 25.08.2025 - Börsentäglich über 12.000 News
Mega-Deal in Kanada: Katapultiert sich diese Aktie jetzt in die Top-Liga der Explorer?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
563 Leser
Artikel bewerten:
(2)

Sectra continues its winning streak of global customer satisfaction with 5 Best in KLAS awards in 2024

LINKÖPING, Sweden and SHELTON, Conn., Feb. 7, 2024 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has won five Best in KLAS awards for its radiology module for enterprise imaging, Sectra PACS. This is the eleventh consecutive year in the US and fifth in Canada that Sectra has been ranked number one in customer satisfaction. Additionally, the new KLAS European categories resulted in Sectra wins for Northern and Southern Europe. The awards are given by the healthcare IT data and insights company KLAS Research.

To read the US and global reports, visit:
https://klasresearch.com/report/2024-best-in-klas-awards-software-and-services/3413
https://klasresearch.com/report/2024-best-in-klas-awards-global-software/3414

"These awards showcase our excellent employees who continuously go above and beyond to meet customer needs. Over the past year, we have restructured our organization into teams to ensure consistent and knowledgeable guidance throughout the sales, implementation, and support phases of the customer journey. This, along with product offerings that reduce IT costs, increase security, and grow with our users' enterprise imaging requirements, has solidified our success," says Marie Ekström Trägårdh, Executive Vice President Sectra AB and President Sectra Imaging IT Solutions.

Sectra 2024 Best in KLAS honors include US Large PACS, US Small PACS, PACS Global (Canada), PACS Global (Northern Europe), and PACS Global (Southern Europe).

The first Sectra PACS installation was in Sweden in 1993, and now, the company has more than 2,500 sites worldwide. The radiology module is an integral part of Sectra's enterprise imaging solution, also comprising VNA and imaging modules for cardiology, orthopedics, ophthalmology, and digital pathology in one single system.

Adam Gale, CEO of KLAS shared his thoughts for the 2024 winners:
"At KLAS, we firmly believe that the voice of healthcare providers and payers is paramount. The Best in KLAS awards are based on extensive feedback and evaluations from healthcare professionals across the nation. Winning a Best in KLAS award, therefore, is not just about recognition; it shows the trust and confidence that healthcare providers place in the winning vendors. It also helps validate each vendor's commitment to innovation, quality, and customer satisfaction. We are proud to recognize 2024's Best in KLAS award winners! Their unwavering dedication to improving patient outcomes is wonderfully inspiring."

Meet Sectra at ECR and HIMSS 2024

Learn more about Sectra and our enterprise imaging solutions at ECR and HIMSS 2024. Join us at booth D02 at ECR and booth #3812 at HIMSS for an in-depth exploration of our offerings.
Book a demo at ECR: https://medical.sectra.com/event/ecr-2024/
Book a demo at HIMSS: https://medical.sectra.com/event/himss24/

About Sectra

Sectra contributes to a healthier and safer society by assisting health systems throughout the world to enhance the efficiency of care, and authorities and defense forces in Europe to protect society's most sensitive information. The company, founded in 1978, is headquartered in Linköping, Sweden, with direct sales in 19 countries, and distribution partners worldwide. Sales in the 2022/2023 fiscal year totaled SEK 2,351 million. The Sectra share is quoted on the Nasdaq Stockholm exchange. For more information, visit Sectra's website.

For further information, please contact:

Dr. Torbjörn Kronander, CEO and President Sectra AB, +46 (0)705 23 52 27
Marie Ekström Trägårdh, Executive Vice President Sectra AB and President Sectra Imaging IT Solutions, +46 (0)708 23 56 10

The following files are available for download:

https://news.cision.com/sectra/i/sectra-s-best-in-klas-awards-2024,c3264395

Sectra's Best In KLAS awards 2024

https://news.cision.com/sectra/i/sectra-s-radiology-solution,c3264396

Sectra's radiology solution

https://news.cision.com/sectra/i/sectra-s-best-in-klas-awards-2024,c3264397

Sectra's Best In KLAS awards 2024

Cision View original content:https://www.prnewswire.co.uk/news-releases/sectra-continues-its-winning-streak-of-global-customer-satisfaction-with-5-best-in-klas-awards-in-2024-302056169.html

© 2024 PR Newswire
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.